| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-12 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.19 | 0.0003 |